PH12021551642A1 - Pharmaceutical composition - Google Patents
Pharmaceutical compositionInfo
- Publication number
- PH12021551642A1 PH12021551642A1 PH1/2021/551642A PH12021551642A PH12021551642A1 PH 12021551642 A1 PH12021551642 A1 PH 12021551642A1 PH 12021551642 A PH12021551642 A PH 12021551642A PH 12021551642 A1 PH12021551642 A1 PH 12021551642A1
- Authority
- PH
- Philippines
- Prior art keywords
- pharmaceutical composition
- branched copolymer
- polyether
- aqueous solution
- active ingredient
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 229920005605 branched copolymer Polymers 0.000 abstract 2
- 239000004721 Polyphenylene oxide Substances 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000007864 aqueous solution Substances 0.000 abstract 1
- 229920000728 polyester Polymers 0.000 abstract 1
- 229920000570 polyether Polymers 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Dermatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Medicinal Preparation (AREA)
- Polyesters Or Polycarbonates (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1900258.3A GB201900258D0 (en) | 2019-01-08 | 2019-01-08 | Pharmaceutical composition |
| PCT/EP2020/050333 WO2020144239A1 (en) | 2019-01-08 | 2020-01-08 | Pharmaceutical composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PH12021551642A1 true PH12021551642A1 (en) | 2022-05-23 |
Family
ID=65528088
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PH1/2021/551642A PH12021551642A1 (en) | 2019-01-08 | 2020-01-08 | Pharmaceutical composition |
Country Status (25)
| Country | Link |
|---|---|
| US (3) | US12485139B2 (enExample) |
| EP (2) | EP4289429A3 (enExample) |
| JP (2) | JP7680355B2 (enExample) |
| KR (1) | KR102958459B1 (enExample) |
| CN (1) | CN113543775B (enExample) |
| AU (1) | AU2020205438B8 (enExample) |
| BR (1) | BR112021013456A2 (enExample) |
| CA (1) | CA3125372A1 (enExample) |
| DK (1) | DK3908321T3 (enExample) |
| EA (1) | EA202191603A1 (enExample) |
| ES (1) | ES2968432T3 (enExample) |
| FI (1) | FI3908321T3 (enExample) |
| GB (1) | GB201900258D0 (enExample) |
| HR (1) | HRP20231667T1 (enExample) |
| HU (1) | HUE064916T2 (enExample) |
| LT (1) | LT3908321T (enExample) |
| MX (1) | MX2021008248A (enExample) |
| PH (1) | PH12021551642A1 (enExample) |
| PL (1) | PL3908321T3 (enExample) |
| PT (1) | PT3908321T (enExample) |
| RS (1) | RS65067B1 (enExample) |
| SI (1) | SI3908321T1 (enExample) |
| SM (1) | SMT202400011T1 (enExample) |
| WO (1) | WO2020144239A1 (enExample) |
| ZA (1) | ZA202104704B (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022069799A1 (en) * | 2020-10-01 | 2022-04-07 | Turku University of Applied Sciences Ltd | A hydrogel material |
| US20250009647A1 (en) | 2021-08-05 | 2025-01-09 | Medincell S.A. | Pharmaceutical composition |
| WO2025104289A1 (en) | 2023-11-17 | 2025-05-22 | Medincell S.A. | Antineoplastic combinations |
| WO2026013080A1 (en) | 2024-07-08 | 2026-01-15 | InnoCore Technologies Holding B.V. | Pharmaceutical composition based on biodegradable polymers comprising polyoxazoline |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2016A (en) | 1841-03-26 | Mode of constructing fireplaces and chimney-staoks ii | ||
| US5225521A (en) | 1991-12-31 | 1993-07-06 | E. I. Du Pont De Nemours And Company | Star-shaped hydroxyacid polymers |
| FR2741628B1 (fr) | 1995-11-29 | 1998-02-06 | Centre Nat Rech Scient | Nouveaux hydrogels a base de copolymeres trisequences et leur application notamment a la liberation progressive de principes actifs |
| AU4648697A (en) | 1996-09-23 | 1998-04-14 | Chandrashekar Pathak | Methods and devices for preparing protein concentrates |
| US6461631B1 (en) | 1999-11-16 | 2002-10-08 | Atrix Laboratories, Inc. | Biodegradable polymer composition |
| KR100416242B1 (ko) | 1999-12-22 | 2004-01-31 | 주식회사 삼양사 | 약물전달체용 생분해성 블록 공중합체의 액체 조성물 및이의 제조방법 |
| US7265186B2 (en) | 2001-01-19 | 2007-09-04 | Nektar Therapeutics Al, Corporation | Multi-arm block copolymers as drug delivery vehicles |
| ES2358416T3 (es) | 2001-10-30 | 2011-05-10 | Novartis Ag | Formulaciones de liberación prolongada de iloperidona y polímero en forma de estrella. |
| US7649023B2 (en) | 2002-06-11 | 2010-01-19 | Novartis Ag | Biodegradable block copolymeric compositions for drug delivery |
| US20050255091A1 (en) | 2004-05-14 | 2005-11-17 | Loomis Gary L | Hydrogels for biomedical applications |
| CN101541857B (zh) * | 2006-11-27 | 2012-12-12 | 阿克塔马克斯手术器材有限责任公司 | 多官能聚环氧烷、水凝胶和组织粘合剂 |
| US9248165B2 (en) * | 2008-11-05 | 2016-02-02 | Hancock-Jaffe Laboratories, Inc. | Composite containing collagen and elastin as a dermal expander and tissue filler |
| US20110070320A1 (en) | 2009-09-23 | 2011-03-24 | Soonkap Hahn | Biodegradable thermoresponsive 3-arm polyethylene glycol poly(lactide-co-glycolide) copolymer for ginseng administration |
| MX347090B (es) | 2010-12-29 | 2017-04-11 | Medincell | Composiciones de suministro de farmacos biodegradables. |
| CN102432852B (zh) | 2011-08-25 | 2013-10-16 | 复旦大学 | 一种聚乳酸基立构复合交联共聚物及其制备方法 |
| JP6134788B2 (ja) | 2012-06-27 | 2017-05-24 | メドインセルル | 疎水性組成物のための生分解性薬物送達 |
| WO2014165923A1 (en) | 2013-04-11 | 2014-10-16 | Commonwealth Scientific And Industrial Research Organisation | Composition for controlled delivery of bioactive agents |
| CA3174824A1 (en) * | 2014-04-21 | 2015-10-29 | Heron Therapeutics, Inc. | Long-acting polymeric delivery systems |
| CN103976976B (zh) | 2014-06-03 | 2016-05-11 | 长春理工大学 | 一种包载重组人生长激素缓释药物微囊的制法 |
| EP4374861A3 (en) | 2015-11-16 | 2024-08-07 | MedinCell S.A. | A method for morselizing and/or targeting pharmaceutically active principles to synovial tissue |
| CN106543454B (zh) | 2016-11-25 | 2019-05-28 | 山东师范大学 | 一种低溶胀可生物降解医用光聚合型水凝胶及其制备方法 |
| CN106832844B (zh) | 2017-02-10 | 2018-11-20 | 四川大学 | 一种四臂peg-pcl、氧化石墨烯复合材料及其制备方法 |
| ES3015765T3 (en) | 2017-07-17 | 2025-05-07 | Medincell S A | Pharmaceutical composition |
| CN108586775B (zh) | 2018-05-04 | 2019-11-12 | 四川大学 | 可用于眼内长期填充的原位交联超支化聚醚类水凝胶及其制备方法 |
-
2019
- 2019-01-08 GB GBGB1900258.3A patent/GB201900258D0/en not_active Ceased
-
2020
- 2020-01-08 HU HUE20700453A patent/HUE064916T2/hu unknown
- 2020-01-08 BR BR112021013456-5A patent/BR112021013456A2/pt unknown
- 2020-01-08 LT LTEPPCT/EP2020/050333T patent/LT3908321T/lt unknown
- 2020-01-08 EP EP23202060.2A patent/EP4289429A3/en active Pending
- 2020-01-08 ES ES20700453T patent/ES2968432T3/es active Active
- 2020-01-08 HR HRP20231667TT patent/HRP20231667T1/hr unknown
- 2020-01-08 MX MX2021008248A patent/MX2021008248A/es unknown
- 2020-01-08 EA EA202191603A patent/EA202191603A1/ru unknown
- 2020-01-08 US US17/421,602 patent/US12485139B2/en active Active
- 2020-01-08 PT PT207004532T patent/PT3908321T/pt unknown
- 2020-01-08 CA CA3125372A patent/CA3125372A1/en active Pending
- 2020-01-08 SM SM20240011T patent/SMT202400011T1/it unknown
- 2020-01-08 CN CN202080017968.9A patent/CN113543775B/zh active Active
- 2020-01-08 KR KR1020217023943A patent/KR102958459B1/ko active Active
- 2020-01-08 DK DK20700453.2T patent/DK3908321T3/da active
- 2020-01-08 EP EP20700453.2A patent/EP3908321B1/en active Active
- 2020-01-08 AU AU2020205438A patent/AU2020205438B8/en active Active
- 2020-01-08 PL PL20700453.2T patent/PL3908321T3/pl unknown
- 2020-01-08 FI FIEP20700453.2T patent/FI3908321T3/fi active
- 2020-01-08 PH PH1/2021/551642A patent/PH12021551642A1/en unknown
- 2020-01-08 SI SI202030342T patent/SI3908321T1/sl unknown
- 2020-01-08 RS RS20240028A patent/RS65067B1/sr unknown
- 2020-01-08 JP JP2021539653A patent/JP7680355B2/ja active Active
- 2020-01-08 WO PCT/EP2020/050333 patent/WO2020144239A1/en not_active Ceased
-
2021
- 2021-07-06 ZA ZA2021/04704A patent/ZA202104704B/en unknown
-
2024
- 2024-05-02 US US18/653,713 patent/US12427165B2/en active Active
- 2024-12-26 JP JP2024229910A patent/JP2025066716A/ja active Pending
-
2025
- 2025-10-29 US US19/373,471 patent/US20260115226A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA202104704B (en) | Pharmaceutical composition | |
| PH12019502325A1 (en) | Sustained release delivery systems comprising traceless linkers | |
| WO2015120110A3 (en) | Novel pharmaceutical formulations | |
| MX2015016112A (es) | Forma de dosificacion resistente al uso indebido que contiene una o mas particulas. | |
| CY1119829T1 (el) | Βιοαποικοδομησιμες συνθεσεις απελευθερωσης φαρμακου | |
| WO2017037593A3 (zh) | 用于减少局部脂肪的医药组成物及其用途 | |
| CL2016001411A1 (es) | Unidad de dosificación farmacéutica solida de desintegración oral que comprende un componente de estetrol; metodo de preparación; uso para la anticoncepción femenina y en terápia de sustitución hormonal femenina. | |
| MX356111B (es) | Composiciones farmaceuticas disuasorias de abuso, de liberacion inmediata. | |
| MX2011010781A (es) | Una crema medicinal hecha con sulfadiazina de plata y quitosano y un proceso para hacerla. | |
| WO2016065096A8 (en) | Platinum-catalyzed silicone drug delivery devices and methods of use thereof | |
| PH12020550009A1 (en) | Pharmaceutical preparation and preparation method therefor | |
| MX382580B (es) | Formulaciones de liberación inmediata disuasivas de abuso que comprenden polisacáridos no celulósicos. | |
| AR022589A1 (es) | UNA CÁPSULA QUE COMPRENDE UNA COMPOSICIoN FARMACÉUTICA ESPONTÁNEAMENTE DISPERSABLE PARA LA ADMINISTRACIoN ORAL, UNA COMPOSICIoN FARMACÉUTICA ESPONTÁNEAMENTE DISPERSABLE PARA LA ADMINISTRACIoN ORAL Y EL USO PARA LA PREPARACIoN DE UN MEDICAMENTO PARA EL TRATAMIENTO DEL CÁNCER | |
| MX2023007741A (es) | Formulaciones de upadacitinib de liberacion prolongada. | |
| WO2018234871A3 (en) | COMPOSITIONS FOR DRUG DELIVERY AND METHODS OF USE | |
| MX2018008868A (es) | Composiciones farmaceuticas que contienen glucomanano con liberacion extendida y propiedades disuasivas de abuso. | |
| ES2130081B1 (es) | Comprimido de maleato de trimebutina con recubrimiento laminar. | |
| MX2022015742A (es) | Formas farmaceuticas osmoticas que comprenden deutetrabenazina y metodos de uso de las mismas. | |
| MX2021014830A (es) | Conjugados de compuestos que comprenden nitrogeno heteroaromatico donador de pares de electrones pi. | |
| ZA202003904B (en) | Drug delivery system | |
| MX2021002459A (es) | Formas de dosificacion en capsula disuasorias del abuso de liberacion inmediata. | |
| WO2012010938A3 (en) | Pharmaceutical composition of cefditoren pivoxil | |
| PH12019501260A1 (en) | A fast disintegrating pharmaceutical composition | |
| WO2011159491A3 (en) | Controlled release levetiracetam formulations | |
| WO2023027670A3 (en) | Lyophilized levosimendan compositions |